Cargando…
Restoring adiponectin via rosiglitazone ameliorates tissue wasting in mice with lung cancer
The cancer associated cachexia syndrome (CACS) is a systemic metabolic disorder resulting in loss of body weight due to skeletal muscle and adipose tissues atrophy. CACS is particularly prominent in lung cancer patients, where it contributes to poor quality of life and excess mortality. Using the Kr...
Autores principales: | Langer, Henning Tim, Ramsamooj, Shakti, Dantas, Ezequiel, Murthy, Anirudh, Ahmed, Mujmmail, Hwang, Seo-Kyoung, Grover, Rahul, Pozovskiy, Rita, Liang, Roger J., Queiroz, Andre Lima, Brown, Justin C, White, Eileen P., Janowitz, Tobias, Goncalves, and Marcus D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10418114/ https://www.ncbi.nlm.nih.gov/pubmed/37577571 http://dx.doi.org/10.1101/2023.07.31.551241 |
Ejemplares similares
-
Blocking ActRIIB and restoring appetite reverses cachexia and improves survival in mice with lung cancer
por: Queiroz, Andre Lima, et al.
Publicado: (2022) -
Systemic Ketone Replacement Does Not Improve Survival or Cancer Cachexia in Mice With Lung Cancer
por: Langer, Henning Tim, et al.
Publicado: (2022) -
TIMP1 is an early biomarker for detection and prognosis of lung cancer
por: Dantas, Ezequiel, et al.
Publicado: (2023) -
GLUT5 (SLC2A5) enables fructose-mediated proliferation independent of ketohexokinase
por: Liang, Roger J., et al.
Publicado: (2021) -
Metformin in combination with rosiglitazone contribute to the increased serum adiponectin levels in people with type 2 diabetes mellitus
por: Nie, Jie-Ming, et al.
Publicado: (2017)